These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37181810)

  • 41. N6-Methyladenosine-Related lncRNA Signature Predicts the Overall Survival of Colorectal Cancer Patients.
    Song W; Ren J; Yuan W; Xiang R; Ge Y; Fu T
    Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573357
    [TBL] [Abstract][Full Text] [Related]  

  • 42. IGF2BP2 promotes pancreatic carcinoma progression by enhancing the stability of B3GNT6 mRNA via m6A methylation.
    Cao P; Wu Y; Sun D; Zhang W; Qiu J; Tang Z; Xue X; Qin L
    Cancer Med; 2023 Feb; 12(4):4405-4420. PubMed ID: 35908253
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of m6A-related genes and m6A RNA methylation regulators in pancreatic cancer and their association with survival.
    Geng Y; Guan R; Hong W; Huang B; Liu P; Guo X; Hu S; Yu M; Hou B
    Ann Transl Med; 2020 Mar; 8(6):387. PubMed ID: 32355831
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Construction and validation of a m6A RNA methylation and ferroptosis-related prognostic model for pancreatic cancer by integrated bioinformatics analysis.
    Wu T; Qian TY; Lin RJ; Jin DD; Xu XB; Huang MX; Ji J; Jiang F; Pan LL; Luo L; Ji YF; Chen QL; Xiao MB
    J Gastrointest Oncol; 2022 Oct; 13(5):2553-2564. PubMed ID: 36388690
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A seven-m6A regulator-related CpG site-based prognostic signature for endometrial carcinoma.
    Zhang X; Pang X; Huang Y; Qian S
    Medicine (Baltimore); 2021 Jul; 100(29):e26648. PubMed ID: 34398021
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comprehensive characterization of tumor microenvironment and m6A RNA methylation regulators and its effects on PD-L1 and immune infiltrates in cervical cancer.
    Ji H; Zhang JA; Liu H; Li K; Wang ZW; Zhu X
    Front Immunol; 2022; 13():976107. PubMed ID: 36091006
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of three m6A-related mRNAs signature and risk score for the prognostication of hepatocellular carcinoma.
    Li Z; Li F; Peng Y; Fang J; Zhou J
    Cancer Med; 2020 Mar; 9(5):1877-1889. PubMed ID: 31943856
    [TBL] [Abstract][Full Text] [Related]  

  • 48. m6A RNA methylation regulators were associated with the malignancy and prognosis of ovarian cancer.
    Zhang C; Liu J; Guo H; Hong D; Ji J; Zhang Q; Guan Q; Ren Q
    Bioengineered; 2021 Dec; 12(1):3159-3176. PubMed ID: 34187307
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development and validation of a novel prognostic signature based on m6A/m5C/m1A-related genes in hepatocellular carcinoma.
    Xiao Y; Li J; Wu J
    BMC Med Genomics; 2023 Jul; 16(1):177. PubMed ID: 37525171
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of N6-methyladenosine (m6A) regulator-related immunogenes on the prognosis and immune microenvironment of breast cancer.
    Yu Z; He Q; Xu G
    Transl Cancer Res; 2022 Dec; 11(12):4303-4314. PubMed ID: 36644186
    [TBL] [Abstract][Full Text] [Related]  

  • 51. LDHA is a prognostic biomarker on the immune response in pancreatic adenocarcinoma and associated with m6A modification.
    Tan Z; Liu J; Xu J; Zhang B; Yu X; Wang W; Liang C
    J Cancer Res Clin Oncol; 2023 Jul; 149(8):4853-4865. PubMed ID: 36269388
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The functions and prognostic values of m6A RNA methylation regulators in thyroid carcinoma.
    Yu ZH; Feng ST; Zhang D; Cao XC; Yu Y; Wang X
    Cancer Cell Int; 2021 Jul; 21(1):385. PubMed ID: 34281544
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Integrative Analysis of m6A RNA Methylation Regulators and the Tumor Immune Microenvironment in Non-Small-Cell Lung Cancer.
    Zhu J; Jiang Y; Wang T; Wu A; Zhou T; Zhang A; Tang Y; Shen Z; Wang J; Zhou H; Shi J; Chen J
    Dis Markers; 2022; 2022():2989200. PubMed ID: 35186164
    [TBL] [Abstract][Full Text] [Related]  

  • 54. m6A-immune-related lncRNA prognostic signature for predicting immune landscape and prognosis of bladder cancer.
    Feng ZH; Liang YP; Cen JJ; Yao HH; Lin HS; Li JY; Liang H; Wang Z; Deng Q; Cao JZ; Huang Y; Wei JH; Luo JH; Chen W; Chen ZH
    J Transl Med; 2022 Oct; 20(1):492. PubMed ID: 36309694
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Development and Validation of an Inflammatory Response-Related Gene Signature for Predicting the Prognosis of Pancreatic Adenocarcinoma.
    Deng ZL; Zhou DZ; Cao SJ; Li Q; Zhang JF; Xie H
    Inflammation; 2022 Aug; 45(4):1732-1751. PubMed ID: 35322324
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of N6-Methyladenosine-Associated Long Non-coding RNAs for Immunotherapeutic Response and Prognosis in Patients With Pancreatic Cancer.
    Yu X; Dong P; Yan Y; Liu F; Wang H; Lv Y; Song M; Yao Q; Hu S
    Front Cell Dev Biol; 2021; 9():748442. PubMed ID: 34621754
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comprehensive analyses indicated the association between m6A related long non-coding RNAs and various pathways in glioma.
    Chen Z; Zhang W; Yan Z; Zhang M
    Cancer Med; 2023 Jan; 12(1):760-788. PubMed ID: 35668574
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic Value of an m6A RNA Methylation Regulator-Based Signature in Patients with Hepatocellular Carcinoma.
    Wu X; Zhang X; Tao L; Dai X; Chen P
    Biomed Res Int; 2020; 2020():2053902. PubMed ID: 32733931
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification and validation of an m6A-related gene signature to predict prognosis and evaluate immune features of breast cancer.
    Li W; Wang X; Li C; Chen T; Zhou X; Li Z; Yang Q
    Hum Cell; 2023 Jan; 36(1):393-408. PubMed ID: 36403174
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of a novel m6A-related lncRNA pair signature for predicting the prognosis of gastric cancer patients.
    Wang JM; Li X; Yang P; Geng WB; Wang XY
    BMC Gastroenterol; 2022 Feb; 22(1):76. PubMed ID: 35189810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.